<DOC>
	<DOC>NCT00510406</DOC>
	<brief_summary>The study will examine the efficacy,safety and tolerability of combination therapy of tamsulosin and solifenacin compared to placebo and monotherapy of tamsulosin and solifenacin in the treatment of males with LUTS associated with BPH.</brief_summary>
	<brief_title>A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH</brief_title>
	<detailed_description>Placebo Solifenacin succinate Tamsulosin hydrochloride Tamsulosin hydrochloride + solifenacin succinate The primary comparison will be the combination treatment with tamsulosin hydrochloride monotherapy. Other comparisons will be: Placebo and combination treatment. Solifenacin monotherapy and combination treatment</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>male patients with LUTS associated with BPH diagnosed &gt; 3 months IPSS score &gt; 13 voiding and storage symptoms maximum flow rate of &gt; 4 mL/s and &lt; 15 mL/s post void residual volume &gt; 200 mL symptomatic urinary tract infection</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Lower Urinary Tract Symptoms</keyword>
	<keyword>Treatment</keyword>
	<keyword>Solifenacin succinate</keyword>
	<keyword>Tamsulosin hydrochloride</keyword>
	<keyword>Prostatic Hyperplasia</keyword>
</DOC>